ArticleHealth psychology report2023
Adjuvant vs. neoadjuvant chemotherapy: quality of life and psychosocial variables in women with breast cancer.
Article in Health psychology report, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 0 citations in OpenAlex.
- Development and content validation of spiritual care e-book for Chinese breast cancer women undergoing chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA breast cancer diagnosis with all that it entails is a highly stressful moment for women. Chemotherapy is one of the main treatments for this type of cancer, and it also brings several side effects and physical changes that often lead to emotional distress and adjustment difficulties. This study aims to analyse the quality of life and psychosocial variables in women with breast cancer submitted to different chemotherapy procedures. PARTICIPANTS AND PROCEDURE: We used a convenience sample of 50 women with breast cancer submitted to adjuvant or neoadjuvant chemotherapy. Women were interviewed after obtaining their informed consent. The instruments used were: a sociodemographic and clinical questionnaire, Functional Assessment of Cancer Therapy-Breast, Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being-12-Item, Positive and Negative Affect Schedule, and Brief Resilient Coping Scale.
resultsParticipants demonstrated reasonable levels of all dimensions analysed, except for resilient coping, which was relatively low. Neither treatment significantly improves quality of life or any other psychosocial variable more than the other. Most of the variables were correlated, especially quality of life.
conclusionsThe results show that the choice of treatment according to the most favourable objective criteria (e.g., stage, patients' characteristics) and multidisciplinary work with the integration of a psychologist are vital to achieve good outcomes and the best possible quality of life. Interesting insights were obtained, such as the need for health literacy to make informed decisions and the variation of needs during the cancer course. Future research could use a longitudinal approach and a more representative sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.